Isu Abxis Co Ltd
KOSDAQ:086890
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Isu Abxis Co Ltd
KOSDAQ:086890
|
KR |
|
Angus Energy PLC
F:A3R
|
UK |
Intrinsic Value
The intrinsic value of Isu Abxis Co Ltd (086890) under the Base Case is 5 836.32 KRW per share. Compared with the current market price of 3 455 KRW, the stock appears Undervalued by 41% .
The intrinsic value is calculated using the DCF method. The model assumes operating margin rises from 2.9% last year to 22% by 2031, above its five-year average of -7.7%. Revenue grows about 18% a year over the next five years, close to its five-year pace of 17%.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Isu Abxis Does
Isu Abxis is a Korean biotech company that develops antibody-based medicines and diagnostic products. Its core work is in making monoclonal antibodies and related biotech tools used in cancer and other disease research, plus some finished products for medical and lab use. In simple terms, it sits between drug discovery and the companies or labs that need those biologic products.
- Headquarters
- Korea KR
- Employees
- 143
- IPO date
- Feb 3, 2009
Revenue & Expenses Breakdown
Isu Abxis Co Ltd
Earnings Waterfall
Isu Abxis Co Ltd
The intrinsic value for Isu Abxis Co Ltd (086890) under the Base Case is 5 836.32 KRW.
Compared with the current market price of 3 455 KRW, the stock appears Undervalued by 41% .